Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HXBM

Helix BioMedix, Inc.

USD

Set alert

Price alert · HXBM

All alert types
3.29 USD 0.00 0.00%
As of Oct 30, 2026
6.02 Day range 6.02
1.00 52-week range 6.50
YTD
+64.50%
1 year
-6.00%
Open
6.02
Prev close
3.29
Mkt cap
739.29K
Vol
100
Avg vol
118
EPS
-1.65
P/E
0.00
More statistics
Low
6.02
High
6.02

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for HXBM has not been loaded yet. Try again in a moment.

Valuation

P/E -0.8×
FY 2008: -2.0×FY 2009: -2.3×FY 2010: -1.0×FY 2011: -5.0×FY 2020: -2.7×FY 2021: -2.0×FY 2022: -4.4×FY 2023: -5.0×FY 2024: -1.8×FY 2025: -0.8×
FY 2008 5y median -2.0× FY 2025
P/S 0.6×
FY 2008: 16.0×FY 2009: 22.3×FY 2010: 9.2×FY 2011: 6.6×FY 2020: 2.8×FY 2021: 1.1×FY 2022: 3.0×FY 2023: 5.2×FY 2024: 2.2×FY 2025: 0.6×
FY 2008 5y median 2.2× FY 2025
P/B 0.3×
FY 2008: -5.2×FY 2009: -1.7×FY 2010: 1.6×FY 2011: 4.9×FY 2020: 2.3×FY 2021: 0.6×FY 2022: 1.4×FY 2023: 1.8×FY 2024: 0.9×FY 2025: 0.3×
FY 2008 5y median 0.9× FY 2025
P/FCF -0.7×
FY 2008: -2.8×FY 2009: -2.8×FY 2010: -2.8×FY 2011: -5.4×FY 2020: -7.2×FY 2021: -3.1×FY 2022: -7.2×FY 2023: -6.0×FY 2024: 0.0×FY 2025: -0.7×
FY 2008 5y median -3.1× FY 2025
EV/EBITDA 1.5×
FY 2008: -3.2×FY 2009: -4.4×FY 2010: -1.3×FY 2011: -4.7×FY 2020: -2.6×FY 2021: 0.2×FY 2022: -1.6×FY 2023: -2.5×FY 2024: 0.1×FY 2025: 1.5×
FY 2008 5y median 0.1× FY 2025
EV/Sales -1.0×
FY 2008: 19.6×FY 2009: 35.0×FY 2010: 4.5×FY 2011: 5.7×FY 2020: 1.7×FY 2021: -0.1×FY 2022: 1.1×FY 2023: 2.7×FY 2024: -0.1×FY 2025: -1.0×
FY 2008 5y median -0.1× FY 2025
FCF Yield -133.7%
FY 2008: -35.3%FY 2009: -35.7%FY 2010: -35.6%FY 2011: -18.5%FY 2020: -13.9%FY 2021: -32.0%FY 2022: -13.9%FY 2023: -16.7%FY 2024: 0.0%FY 2025: -133.7%
FY 2008 5y median -16.7% FY 2025

Profitability

Gross Margin 99.4%
FY 2008: 30.9%FY 2009: 16.4%FY 2010: 56.1%FY 2011: 55.5%FY 2020: 94.4%FY 2021: 81.3%FY 2022: 99.1%FY 2023: 99.0%FY 2024: 99.2%FY 2025: 99.4%
FY 2008 5y median 99.1% FY 2025
Operating Margin -73.8%
FY 2008: -629.7%FY 2009: -822.4%FY 2010: -347.1%FY 2011: -127.1%FY 2020: -67.0%FY 2021: -55.8%FY 2022: -61.5%FY 2023: -98.6%FY 2024: -132.3%FY 2025: -73.8%
FY 2008 5y median -73.8% FY 2025
Net Margin -68.3%
FY 2008: -802.2%FY 2009: -964.8%FY 2010: -905.4%FY 2011: -131.6%FY 2020: -101.0%FY 2021: -57.3%FY 2022: -67.9%FY 2023: -105.8%FY 2024: -122.1%FY 2025: -68.3%
FY 2008 5y median -68.3% FY 2025
ROE -35.8%
FY 2008: 263.4%FY 2009: 73.0%FY 2010: -158.2%FY 2011: -98.2%FY 2020: -82.8%FY 2021: -28.8%FY 2022: -31.3%FY 2023: -35.7%FY 2024: -47.1%FY 2025: -35.8%
FY 2008 5y median -35.7% FY 2025
ROIC -38.7%
FY 2008: -236.8%FY 2009: -172.1%FY 2010: -60.2%FY 2011: -93.8%FY 2020: -23.7%FY 2021: -27.9%FY 2022: -27.8%FY 2023: -33.3%FY 2024: -51.0%FY 2025: -38.7%
FY 2008 5y median -33.3% FY 2025
ROA -32.9%
FY 2008: -167.0%FY 2009: -187.5%FY 2010: -147.5%FY 2011: -83.7%FY 2020: -32.9%FY 2021: -28.1%FY 2022: -30.3%FY 2023: -34.9%FY 2024: -44.4%FY 2025: -32.9%
FY 2008 5y median -32.9% FY 2025

Growth (YoY)

Revenue 0.4%
FY 2008: 21.3%FY 2009: -30.5%FY 2010: 117.7%FY 2011: 122.1%FY 2020: 0.0%FY 2021: 29.3%FY 2022: -26.1%FY 2023: -43.1%FY 2024: -19.4%FY 2025: 0.4%
FY 2008 FY 2025
Operating Income 44.0%
FY 2008: -0.7%FY 2009: 9.2%FY 2010: 8.1%FY 2011: 18.7%FY 2020: 0.0%FY 2021: -7.5%FY 2022: 18.5%FY 2023: 8.8%FY 2024: -8.1%FY 2025: 44.0%
FY 2008 FY 2025
EPS (diluted) 43.9%
FY 2008: -28.9%FY 2009: 16.4%FY 2010: -93.2%FY 2011: 82.4%FY 2020: 0.0%FY 2021: 33.0%FY 2022: 12.2%FY 2023: 11.5%FY 2024: 7.0%FY 2025: 43.9%
FY 2008 FY 2025
Free Cash Flow 0.0%
FY 2008: 2.1%FY 2009: 1.8%FY 2010: 10.0%FY 2011: 18.0%FY 2020: 0.0%FY 2021: -21.7%FY 2022: 15.4%FY 2023: -19.5%FY 2024: 0.0%FY 2025: 0.0%
FY 2008 FY 2025

Financial Health

Current Ratio 12.2×
FY 2008: 1.8×FY 2009: 11.5×FY 2010: 14.7×FY 2011: 6.2×FY 2020: 1.7×FY 2021: 55.3×FY 2022: 30.2×FY 2023: 45.0×FY 2024: 17.6×FY 2025: 12.2×
FY 2008 5y median 30.2× FY 2025
Quick Ratio 12.2×
FY 2008: 1.7×FY 2009: 10.1×FY 2010: 13.8×FY 2011: 5.3×FY 2020: 1.6×FY 2021: 55.3×FY 2022: 30.2×FY 2023: 45.0×FY 2024: 17.6×FY 2025: 12.2×
FY 2008 5y median 30.2× FY 2025
Debt / Equity 0.0×
FY 2008: -1.7×FY 2009: -1.2×FY 2010: 0.0×FY 2011: 0.0×FY 2020: 1.3×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2008 5y median 0.0× FY 2025
Net Debt / EBITDA 2.3×
FY 2008: -0.6×FY 2009: -1.6×FY 2010: 1.4×FY 2011: 0.7×FY 2020: 1.6×FY 2021: 2.9×FY 2022: 2.9×FY 2023: 2.5×FY 2024: 1.9×FY 2025: 2.3×
FY 2008 5y median 2.5× FY 2025
Interest Coverage 0.0×
FY 2008: -3.4×FY 2009: -6.6×FY 2010: -4.4×FY 2011: 0.0×FY 2020: -1.9×FY 2021: -3.8×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2008 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2008 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2008: 0.0%FY 2009: 0.0%FY 2010: 0.0%FY 2011: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2008 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31